Pharmacology Flashcards
Define pharmacology
the science of drugs, their MOA, how their effects can be measured, their discovery, design and development, their actions on the organism and the actions of the organism on them.
What are the three types of names a drug has?
chemical, generic, trademarked
What kinds of drugs are able to be purchased over the counter?
those with high therapeutic indexes which means that a dose of the drug that may cause toxicitiy is hugely different from a therapeutic dose.
What are the 4 drug targets?
receptors, ion channels, enzymes & transporters
Why do drugs interact with some receptors, transporters, or enzymes but not others?
binding of the drug is very specific and if the receptor is activated change can occur within the cell. These interactions may be based on charge, hydophilicity/phobicity or shape.
Where are target receptors found?
can be on the cell membrane or intracellular
Name the 4 types of receptors from fastest acting to slowest.
ligand-gated ion channels, g-protein coupled receptors, kinase-linked receptors & nuclear receptors
What is the most common drug target?
G-protein coupled receptors (~40%)
Ligand-gated ion channels (onset, location, MOA, i.e.)
located on the cell surface
rapid-acting (milliseconds)
opens ion channels to allow direct movement of ions
i.e. nicotinic acetylcholine receptors.
AKA ionotropic repectors.
G-protein coupled receptors (onset, location, MOA, i.e.)
located on the cell surface
acts in seconds to minutes
activates a second messenger within the cell
i.e. beta-adrenoreceptor.
Why do g-protein coupled receptors often vary in response?
due to differing alpha subunits and intracellular second messengers
Describe the 4 step process of a g-protein coupled receptor being activated by a drug
- starts in a resting state
- agonist drug binds with receptor and alpha unit bound GDP (inactive) interacts with intracellular GTP (active)
- GTP dissociates from receptor and activates the target protein, while the other subunits (b & y) may also activate a 2nd target protein
- GTP hydrolysis occurs and the alpha subunit returns to the receptor
Kinase-linked receptors (onset, location, MOA, i.e.)
located on the cell surface
acts in minutes to hours
activates an enzyme cascade effect via a change in receptor shape within the cell
i.e. insulin receptors
What process is of particular relevance for kinase-linked receptors?
amplification (because they use a cascade effect)
What two changes occur during the kinase pathway after being activated by a drug?
kinase (adding a phosphate)
phosphatase (removing a phosphate)
Nuclear receptors (onset, location, MOA, i.e.)
intracellular
slowest acting (hours)
ligands cross the cell membrane directly and bind with receptors within the cell
i.e. estrogen receptor
Describe the process of a nuclear receptor being activated by a drug
ligands/hormones move across cell membrane and interact with the receptor within the cell
the hormone & receptor both migrate to the DNA within the nucleus, binding to key sequences in the DNA to cause transcription of desired proteins
biological action is then caused by mRNA synthesising new proteins within the cytoplasm
What affect do drugs have by targetting transporters?
blocking the transporters actions and not allowing the uptake of molecules
Give an example of a drug that targets transporters
anti-depressive drugs target a serotonin transporter located on the presynaptic side of a synapse
by doing this serotonin levels stay increased for a longer period increasing the chance that they will bind to receptors and thus improve signalling
Describe the MOA of drugs that target enzymes
these types of drugs (whether agonistic or antagonistic) closely resemble a substrate that an enzyme would normally bind with
often called a ‘lock & key’ mechanism these drugs can bind with the enzyme and either elicit a response (agonist) or block the natural agonist from eliciting a response (antagonist)
Enzyme inhibition can be described as what?
competitive, non-competitive, uncompetitive or functional
What is the difference between competitive and non-competitive inhibition?
competitive involves a drug binding with the active site on an enzyme and blocking the action of another substrate
non-competitive involves a drug binding to a secondary site (aka allosteric site) and changing the shape of the enzyme’s active site, disallowing a substrate to bind as it will no longer ‘fit’
What is the difference between an agonist drug and antagonist drug?
agonist produces a physiological change by binding to it’s receptor
antagonist clocks a normal physiological response by blocking its receptor from binding to other substrates
Are all agonists as effective as each other?
no- agonists can be high or low affinity agonists
high affinity means they will bind more readily, low affinity means there might need to be a higher concentration present to create the same effect